Delivery of over 29 lakh Covishield doses facilitated by Mumbai airport

Published On 2021-01-15 07:38 GMT   |   Update On 2021-01-15 07:38 GMT

Mumbai: Mumbai airport on Thursday said it has facilitated cumulative delivery of 29,28,000 doses of Covishield vaccine across 25 destinations in the country since Wednesday. The city's Chhatrapati Shivaji Maharaj International Airport (CSMIA) started handling flights carrying Covid-19 vaccines from January 13.CSMIA facilitated the delivery of a total 244 boxes of Covisheld vaccine,...

Login or Register to read the full article

Mumbai: Mumbai airport on Thursday said it has facilitated cumulative delivery of 29,28,000 doses of Covishield vaccine across 25 destinations in the country since Wednesday. The city's Chhatrapati Shivaji Maharaj International Airport (CSMIA) started handling flights carrying Covid-19 vaccines from January 13.

CSMIA facilitated the delivery of a total 244 boxes of Covisheld vaccine, carrying 28,44,000 doses, to Goa, Bagdogra, Faizabad, Rajkot, Ranchi, Imphal, Agartala, Cochin, Bhopal, Kanpur, Jammu, Srinagar, Lucknow, Chandigarh, Gorakhpur, Raipur, Dehradun, Varanasi, Indore, Trivandrum, Jabalpur on January 13, the private airport operator said in a release.
On Thursday, flights to Delhi, Dimapur, Guwahati, Chandigarh and Cochin are being operated, carrying 84,000 doses of Covishield vaccine in seven boxes, it said.
The Mumbai airport said the standard operating procedures (SOPs) implemented by it in anticipation of vaccine distribution saw the terminal register a cargo processing time of just seven minutes, right from goods acceptance to dispatch at the ramp, it added.
Besides, the airport has deployed a dedicated Covid-19 task force to reduce dwell time and facilitate advance planning and collaboration between the airport and all stakeholders in this process.

Read also: COVID-19 vaccine: 1.1 crore Covidshield vaccines procured for Rs 200 per dose, 55 Lakh Covaxin for Rs 206 per piece



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News